Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, June 21, 2022
[ Tue, Jun 21st 2022
] - WOPRAI
[ Tue, Jun 21st 2022
] - WOPRAI
[ Tue, Jun 21st 2022
] - WOPRAI
[ Tue, Jun 21st 2022
] - WOPRAI
[ Tue, Jun 21st 2022
] - WOPRAI
[ Tue, Jun 21st 2022
] - WOPRAI
[ Tue, Jun 21st 2022
] - WOPRAI
[ Tue, Jun 21st 2022
] - WOPRAI
[ Tue, Jun 21st 2022
] - WOPRAI
[ Tue, Jun 21st 2022
] - WOPRAI
[ Tue, Jun 21st 2022
] - WOPRAI
[ Tue, Jun 21st 2022
] - WOPRAI
[ Tue, Jun 21st 2022
] - WOPRAI
Sun, June 19, 2022
[ Sun, Jun 19th 2022
] - WOPRAI
Fri, June 17, 2022
[ Fri, Jun 17th 2022
] - WOPRAI
[ Fri, Jun 17th 2022
] - WOPRAI
[ Fri, Jun 17th 2022
] - WOPRAI
[ Fri, Jun 17th 2022
] - WOPRAI
[ Fri, Jun 17th 2022
] - WOPRAI
[ Fri, Jun 17th 2022
] - WOPRAI
[ Fri, Jun 17th 2022
] - WOPRAI
[ Fri, Jun 17th 2022
] - WOPRAI
[ Fri, Jun 17th 2022
] - WOPRAI
[ Fri, Jun 17th 2022
] - WOPRAI
[ Fri, Jun 17th 2022
] - WOPRAI
[ Fri, Jun 17th 2022
] - WOPRAI
[ Fri, Jun 17th 2022
] - WOPRAI
[ Fri, Jun 17th 2022
] - WOPRAI
[ Fri, Jun 17th 2022
] - WOPRAI
[ Fri, Jun 17th 2022
] - WOPRAI
Kostas Biliouris Initiated (BEAM) at Hold and Held Target at $41 on, Jun 17th, 2022
Kostas Biliouris of BMO Capital, Initiated "Beam Therapeutics Inc." (BEAM) at Hold and Held Target at $41 on, Jun 17th, 2022.
Kostas has made no other calls on BEAM in the last 4 months.
There are 2 other peers that have a rating on BEAM. Out of the 2 peers that are also analyzing BEAM, 1 agrees with Kostas's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Richard Law of "Credit Suisse" Initiated at Hold and Held Target at $62 on, Thursday, April 28th, 2022
This is the rating of the analyst that currently disagrees with Kostas
- Rick Bienkowski of "SVB Leerink" Maintained at Buy with Increased Target to $121 on, Monday, May 9th, 2022
